We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Seegene Inc, a South Korean biotechnology firm, announced the launch of a SARS-CoV-2 variant diagnostic test capable of detecting new virus variants including the Delta and the Delta Plus that have become the dominant virus around the world.
India, already hit hard by the Delta variant of COVID-19, has labeled a closely related new variant -- dubbed "Delta Plus" -- as a "variant of concern."